Table of Contents Chapter 1 Overview of Antivenom 1.1 Definition of Antivenom in This Report 1.2 Commercial Types of Antivenom 1.2.1 Humans 1.2.2 Animals 1.3 Downstream Application of Antivenom 1.3.1 Monovalent 1.3.2 Polyvalent 1.4 Development History of Antivenom 1.5 Market Status and Trend of Antivenom 2013-2023 1.5.1 Global Antivenom Market Status and Trend 2013-2023 1.5.2 Regional Antivenom Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Antivenom 2013-2017 2.2 Production Market of Antivenom by Regions 2.2.1 Production Volume of Antivenom by Regions 2.2.2 Production Value of Antivenom by Regions 2.3 Demand Market of Antivenom by Regions 2.4 Production and Demand Status of Antivenom by Regions 2.4.1 Production and Demand Status of Antivenom by Regions 2013-2017 2.4.2 Import and Export Status of Antivenom by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Antivenom by Types 3.2 Production Value of Antivenom by Types 3.3 Market Forecast of Antivenom by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Antivenom by Downstream Industry 4.2 Market Forecast of Antivenom by Downstream Industry Chapter 5 Market Driving Factor Analysis of Antivenom 5.1 Global Economy Situation and Trend Overview 5.2 Antivenom Downstream Industry Situation and Trend Overview Chapter 6 Antivenom Market Competition Status by Major Manufacturers 6.1 Production Volume of Antivenom by Major Manufacturers 6.2 Production Value of Antivenom by Major Manufacturers 6.3 Basic Information of Antivenom by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Antivenom Major Manufacturer 6.3.2 Employees and Revenue Level of Antivenom Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Antivenom Major Manufacturers Introduction and Market Data 7.1 Merck 7.1.1 Company profile 7.1.2 Representative Antivenom Product 7.1.3 Antivenom Sales, Revenue, Price and Gross Margin of Merck 7.2 Summerland Serums (AU) 7.2.1 Company profile 7.2.2 Representative Antivenom Product 7.2.3 Antivenom Sales, Revenue, Price and Gross Margin of Summerland Serums (AU) 7.3 Haffkine Bio Pharmaceutical 7.3.1 Company profile 7.3.2 Representative Antivenom Product 7.3.3 Antivenom Sales, Revenue, Price and Gross Margin of Haffkine Bio Pharmaceutical 7.4 MicroPharm 7.4.1 Company profile 7.4.2 Representative Antivenom Product 7.4.3 Antivenom Sales, Revenue, Price and Gross Margin of MicroPharm 7.5 CSL (AU) 7.5.1 Company profile 7.5.2 Representative Antivenom Product 7.5.3 Antivenom Sales, Revenue, Price and Gross Margin of CSL (AU) 7.6 SAVP 7.6.1 Company profile 7.6.2 Representative Antivenom Product 7.6.3 Antivenom Sales, Revenue, Price and Gross Margin of SAVP 7.7 Flynn Pharma 7.7.1 Company profile 7.7.2 Representative Antivenom Product 7.7.3 Antivenom Sales, Revenue, Price and Gross Margin of Flynn Pharma 7.8 Serum 7.8.1 Company profile 7.8.2 Representative Antivenom Product 7.8.3 Antivenom Sales, Revenue, Price and Gross Margin of Serum Chapter 8 Upstream and Downstream Market Analysis of Antivenom 8.1 Industry Chain of Antivenom 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Antivenom 9.1 Cost Structure Analysis of Antivenom 9.2 Raw Materials Cost Analysis of Antivenom 9.3 Labor Cost Analysis of Antivenom 9.4 Manufacturing Expenses Analysis of Antivenom Chapter 10 Marketing Status Analysis of Antivenom 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Humans Table Advantage and Disadvantage of Animals Table Production Volume of Antivenom by Regions 2013-2017 Table Production Value of Antivenom by Regions 2013-2017 Table Demand Volume of Antivenom by Regions 2013-2017 Table Production and Demand Status of Antivenom in Region One 2013-2017 Table Production and Demand Status of Antivenom in Region Two 2013-2017 Table Production and Demand Status of Antivenom in Region Three 2013-2017 Table Production and Demand Status of Antivenom in Region Four 2013-2017 Table Import Volume of Antivenom by Regions 2013-2017 Table Export Volume of Antivenom by Regions 2013-2017 Table Production Volume of Antivenom by Types 2013-2017 Table Production Value of Antivenom by Types 2013-2017 Table Production Volume Forecast of Antivenom by Types 2018-2023 Table Production Value Forecast of Antivenom by Types 2018-2023 Table Demand Volume of Antivenom by Downstream Industry 2013-2017 Table Demand Volume Forecast of Antivenom by Downstream Industry 2018-2023 Table Production Volume of Antivenom by Major Manufacturers 2013-2017 Table Production Value of Antivenom by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Antivenom Major Manufacturer Table Employees and Revenue Level of Antivenom Major Manufacturer Table Representative Antivenom Product One of Merck Table Representative Antivenom Product Two of Merck Table Antivenom Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Antivenom Product One of Summerland Serums (AU) Table Representative Antivenom Product Two of Summerland Serums (AU) Table Antivenom Sales, Revenue, Price and Gross Margin of Summerland Serums (AU) 2013-2017 Table Representative Antivenom Product One of Haffkine Bio Pharmaceutical Table Representative Antivenom Product Two of Haffkine Bio Pharmaceutical Table Antivenom Sales, Revenue, Price and Gross Margin of Haffkine Bio Pharmaceutical 2013-2017 Table Representative Antivenom Product One of MicroPharm Table Representative Antivenom Product Two of MicroPharm Table Antivenom Sales, Revenue, Price and Gross Margin of MicroPharm 2013-2017 Table Representative Antivenom Product One of CSL (AU) Table Representative Antivenom Product Two of CSL (AU) Table Antivenom Sales, Revenue, Price and Gross Margin of CSL (AU) 2013-2017 Table Representative Antivenom Product One of SAVP Table Representative Antivenom Product Two of SAVP Table Antivenom Sales, Revenue, Price and Gross Margin of SAVP 2013-2017 Table Representative Antivenom Product One of Flynn Pharma Table Representative Antivenom Product Two of Flynn Pharma Table Antivenom Sales, Revenue, Price and Gross Margin of Flynn Pharma 2013-2017 Table Representative Antivenom Product One of Serum Table Representative Antivenom Product Two of Serum Table Antivenom Sales, Revenue, Price and Gross Margin of Serum 2013-2017